Business Context and Reporting Period
This Form 8-K was filed by Brilliant Acquisition Corporation, not T3 Defense Inc., on November 22, 2023. Brilliant is a special purpose acquisition company pursuing a proposed business combination with Nukkleus, Inc. under a merger agreement originally dated February 22, 2022, and amended and restated June 23, 2023.
Key Financial and Capital-Structure Information
- Brilliant issued unsecured, non-interest-bearing promissory notes totaling $32,300.
- The notes comprise $16,150 issued to Brilliant’s sponsor, Nisun Investment Holding Limited, and $16,150 issued to Nukkleus.
- The notes mature upon closing of Brilliant’s initial business combination.
- If no business combination is completed, repayment is limited to amounts remaining outside Brilliant’s trust account, if any.
- Note proceeds were deposited into the trust account in connection with extending the business-combination completion window.
- This filing does not provide revenue, profit, cash-flow, margin, debt-balance, or liquidity metrics beyond the promissory-note issuance described above.
Material Changes Versus the Prior Comparable Period
- Brilliant extended its deadline to complete an initial business combination by one month, to December 23, 2023.
- The company incurred a new $32,300 unsecured obligation through the issuance of the notes.
- The filing does not provide comparative operating or financial results for a prior period.
Guidance, Outlook, Risks, and Unusual Items
Management’s stated objective is to complete the proposed Nukkleus transaction within the extended period. Completion remains subject to required shareholder approvals, satisfaction of the minimum trust-account condition after redemptions, regulatory approvals, and other closing conditions.
- The proposed business combination may not close by December 23, 2023, or may not close at all.
- Failure to complete a business combination could result in repayment of the notes only from funds outside the trust account, if any.
- Additional risks include shareholder redemptions, litigation, regulatory developments, Nasdaq listing requirements, business disruption, employee-retention issues, market volatility, and the parties’ ability to execute post-closing plans.
- The filing includes forward-looking statements and cautions investors not to rely on them unduly.
- The press release furnished as Exhibit 99.1 is not deemed filed for purposes of Section 18 of the Exchange Act.
Important Facts for Investors to Verify
- Confirm that the relevant registrant is Brilliant Acquisition Corporation; the supplied filing does not identify T3 Defense Inc.
- Review the full promissory-note form filed as Exhibit 10.1, including repayment and maturity provisions.
- Verify the status of the Nukkleus merger, shareholder approvals, regulatory approvals, redemption levels, and minimum trust-account requirement.
- Confirm whether Brilliant completed a business combination by the December 23, 2023 deadline or obtained any further extension.
- Review the Form S-4, proxy statement/prospectus, and applicable risk factors before making an investment or voting decision.